Some properties of blood stored in anticoagulant CPDA-1 solution. A brief summary.
Approval of the new anticoagulant preservative, CPDA-1, was based in part on data from human clinical trials of CPDA-1 performed by six cooperating laboratories and two blood bag manufacturers. Biochemical and red blood cell survival properties of 123 units of blood stored for 28 to 35 days in CPDA-1 (as reported by cooperating laboratories) are briefly summarized.
D000225:Adenine / Q000494:pharmacology; D000925:Anticoagulants; D001769:Blood; D001793:Blood Preservation; D002470:Cell Survival; D002951:Citrates / Q000494:pharmacology; D004912:Erythrocytes / Q000502:physiology; D005947:Glucose / Q000494:pharmacology; D006400:Hematocrit; D006801:Humans; D010710:Phosphates / Q000494:pharmacology; D012996:Solutions
D000925:Anticoagulants; D002951:Citrates; D010710:Phosphates; D012996:Solutions; D005947:Glucose; D000225:Adenine